OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gout
Nicola Dalbeth, Anna L. Gosling, Angelo Gaffo, et al.
The Lancet (2021) Vol. 397, Iss. 10287, pp. 1843-1855
Closed Access | Times Cited: 778

Showing 1-25 of 778 citing articles:

NF-κB in biology and targeted therapy: new insights and translational implications
Qing Guo, Yizi Jin, Xinyu Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 394

The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases
Hallie Blevins, Yiming Xu, Savannah Biby, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 259

Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Yanlin Wu, Zhengjun Lin, Changchun Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 180

Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout
Edoardo Cipolletta, Laila J. Tata, Georgina Nakafero, et al.
JAMA (2022) Vol. 328, Iss. 5, pp. 440-440
Open Access | Times Cited: 134

TET2-mutant clonal hematopoiesis and risk of gout
Mridul Agrawal, Abhishek Niroula, Pierre Cunin, et al.
Blood (2022) Vol. 140, Iss. 10, pp. 1094-1103
Open Access | Times Cited: 106

Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout
Zhilei Wang, Yuchen Li, Wenhao Liao, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 81

Role of NLRP3 in the pathogenesis and treatment of gout arthritis
Yaru Liu, Jiequan Wang, Jun Li
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 62

Uric acid in health and disease: From physiological functions to pathogenic mechanisms
Shijie Wen, Hiroshi Arakawa, Ikumi Tamai
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108615-108615
Closed Access | Times Cited: 61

Materials engineering strategies for cancer vaccine adjuvant development
Xuanbo Zhang, Bowei Yang, Qianqian Ni, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 9, pp. 2886-2910
Open Access | Times Cited: 56

Stimulus‐Responsive Hydrogels as Drug Delivery Systems for Inflammation Targeted Therapy
Haoyu Yu, Rongyao Gao, Yuxin Liu, et al.
Advanced Science (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 46

2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice
Péter Mandl, Maria Antonietta DʼAgostino, Victoria Navarro‐Compán, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 6, pp. 752-759
Open Access | Times Cited: 27

Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
Marita Cross, Kanyin Liane Ong, Garland T Culbreth, et al.
The Lancet Rheumatology (2024) Vol. 6, Iss. 8, pp. e507-e517
Open Access | Times Cited: 26

Plasma aldosterone concentrations elevation in hypertensive patients: the dual impact on hyperuricemia and gout
Shuaiwei Song, Xintian Cai, Junli Hu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 21

Epidemiology of gout – Global burden of disease research from 1990 to 2019 and future trend predictions
Tingfen Han, Wenli Chen, Xiasang Qiu, et al.
Therapeutic Advances in Endocrinology and Metabolism (2024) Vol. 15
Open Access | Times Cited: 19

Intestinal toxicity alleviation and efficacy potentiation through therapeutic administration of Lactobacillus paracasei GY-1 in the treatment of gout flares with colchicine
Jiaqi Zeng, Yan Li, Yizhi Zou, et al.
Food & Function (2024) Vol. 15, Iss. 3, pp. 1671-1688
Closed Access | Times Cited: 18

Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker
Hang‐Korng Ea, Brenda Kischkel, T.W. Chirayath, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 7, pp. 945-956
Closed Access | Times Cited: 16

KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Olivier Devuyst, Curie Ahn, Thijs R.M. Barten, et al.
Kidney International (2025) Vol. 107, Iss. 2, pp. S1-S239
Open Access | Times Cited: 4

Microalgae-based drug delivery microspheres for treatment of hyperuricemia with renal injury
Xiaoyang Liu, Jiajia Dong, Jiarong Cui, et al.
Nano Today (2025) Vol. 61, pp. 102607-102607
Closed Access | Times Cited: 2

Mechanisms of urate transport and uricosuric drugs inhibition in human URAT1
Wenjun Guo, Miao Wei, Yunfeng Li, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2

The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout—An Update
Robert Eckenstaler, Ralf A. Benndorf
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6678-6678
Open Access | Times Cited: 77

Lactobacillus paracasei X11 Ameliorates Hyperuricemia and Modulates Gut Microbiota in Mice
Jiayuan Cao, Qiqi Liu, Haining Hao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 63

Inflammatory Response to Regulated Cell Death in Gout and Its Functional Implications
Jianan Zhao, Kai Wei, Ping Jiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 62

Page 1 - Next Page

Scroll to top